IRF1 and acute myeloid leukemia: IHC staining for Ki67 revealed a notable decrease in Ki67-positive cells within the IRF1 knockdown group (Fig. 4E, F).The aforementioned results confirm that IRF1 knockdown inhibits AML progression in vivo.